Standard Biotools Inc. · NASDAQ:LAB

Long Focus Capital Management, LLC reported a 6.00% stake in Standard Biotools Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 14, 2026

Long Focus Capital Management, LLC reported a 6.00% stake in Standard Biotools Inc., 23,500,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).

Stake
6.00%
Shares
23,500,000
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
LONG FOCUS CAPITAL MANAGEMENT, LLC6.00%23,500,000
JOHN HELMERS6.00%23,500,000

Source

View original at SEC

Related